AbbVie Operating Expenses 2012-2026 | ABBV

AbbVie operating expenses for the twelve months ending March 31, 2026 were $47.487B, a 0.41% increase year-over-year.

  • AbbVie annual operating expenses for 2025 were $46.085B, a 2.36% decline from 2024.
  • AbbVie annual operating expenses for 2024 were $47.197B, a 13.56% increase from 2023.
  • AbbVie annual operating expenses for 2023 were $41.561B, a 4.07% increase from 2022.

AbbVie Operating Expenses 2012-2026 | ABBV

  • AbbVie annual operating expenses for 2025 were $46.085B, a 2.36% decline from 2024.
  • AbbVie annual operating expenses for 2024 were $47.197B, a 13.56% increase from 2023.
  • AbbVie annual operating expenses for 2023 were $41.561B, a 4.07% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B